Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05144191 · ClinicalTrials.gov registry record · NA

Insignia™ Hip Stem Outcomes Study

A NA study of Rheumatoid Arthritis and Surgery, sponsored by Stryker Orthopaedics.

Active
Registry status
NA
Development phase
313
Enrollment target
11
Study locations

NCT05144191 is a NA study of Rheumatoid Arthritis and Surgery that is active but no longer recruiting, run by Stryker Orthopaedics. The registered enrollment target is 313 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (93% lower). The trial reports 11 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05144191, a NA study of Rheumatoid Arthritis and Surgery, is active but no longer recruiting, sponsored by Stryker Orthopaedics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
313 participants
Enrollment target
11
Study locations

Study Summary

The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.

Conditions Studied

Rheumatoid Arthritis Surgery Avascular Necrosis Hip Osteoarthritis Post-traumatic Osteoarthritis Femoral Neck Fractures Trochanteric Fractures

Interventions

  • DEVICE Insignia uncemented Hip Stem

Study Locations (11)

Washington

  • Orthopedic Physician Associates - Seattle
  • Providence Orthopedics and Sports Medicine - Spokane

Arizona

  • The MORE Foundation - Phoenix

California

  • University of California, San Francisco - San Francisco

Illinois

  • Midwest Orthopaedics at Rush - Chicago

Nevada

  • Reno Orthopedic Center Foundation - Reno

New York

  • Northwell Health: University Orthopaedic Associates - Great Neck

North Carolina

  • OrthoCarolina Research Institute - Charlotte

Pennsylvania

  • Alleghany Health Network- Research Institute - Pittsburgh

Trial Details

FieldValue
Enrollment Target 313 participants
Start Date 2022-02-07
Est. Completion 2034-04-02
Phase NA

Sponsor

Stryker Orthopaedics

27 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05144191

The ClinicalTrials.gov registry entry for NCT05144191 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 313 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (93% lower). The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Insignia uncemented Hip Stem is the first listed.

NCT05144191 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Washington, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT05144191 about?

NCT05144191 is a clinical study titled "Insignia™ Hip Stem Outcomes Study". The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.

What is the current status of trial NCT05144191?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 313 participants. The study started on 2022-02-07. Estimated completion is 2034-04-02.

What conditions does trial NCT05144191 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Surgery, Avascular Necrosis, Hip Osteoarthritis, Post-traumatic Osteoarthritis.

What interventions are being tested in trial NCT05144191?

The interventions under investigation include: Insignia uncemented Hip Stem (DEVICE).

Who is sponsoring clinical trial NCT05144191?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05144191 being conducted?

This trial has 11 study locations across Arizona, California, Illinois, Nevada, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Surgery

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.